Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
La Corporation De L’École Des Hautes Études Commerciales De Montréal is currently active in the Biotechnology & Pharmaceuticals technology area, with 1 pending office action on file. This activity represents the current efforts to protect biological or pharmaceutical innovations. Navigating the complex requirements of the Biotechnology & Pharmaceuticals sector is a key part of the intellectual property strategy as it moves through the prosecution phase.
The portfolio's pending matters are reviewed by 1 distinct examiner and are located within 1 distinct art unit. This concentration indicates that the technical scope of the applications is specialized enough to be handled by a single administrative group. For the applicant, this means that the prosecution strategy can be tailored to the specific standards of 1 distinct art unit. This focused approach can lead to a more predictable examination experience for the 1 distinct examiner assigned.
OLJUSKIN, TIMUR YURYEVICH is the busiest examiner for this portfolio, currently managing 1 busiest examiner pending office action. As the only examiner with a pending matter, OLJUSKIN, TIMUR YURYEVICH holds a central role in determining the outcome of the current patent applications. Practitioners should monitor the specific examination tendencies of this official to effectively address the 1 busiest examiner pending office action. This centralized review structure allows for direct communication with the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WISE, OLIVIA M. | 1 | 33.9% | +29.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17868417 | METHOD AND APPARATUS FOR DETERMINING MOLECULAR CONFORMATION | WISE, OLIVIA M. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17868417 | METHOD AND APPARATUS FOR DETERMINING MOLECULAR CONFORMATION | WISE, OLIVIA M. | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17868417 | METHOD AND APPARATUS FOR DETERMINING MOLECULAR CONFORMATION | WISE, OLIVIA M. | 1685 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial